What is NDC 64980-661?

64980-661 is the product NDC for sumatriptan, Sumatriptan succinate 50 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for sumatriptan?

76 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

sumatriptan NDC 64980-661 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)64980-661Labeler and product segments. Claims need a package NDC.

Product NDC at billing width64980-0661Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
64980-661-27	64980066127	3 BLISTER PACK in 1 CARTON (64980-661-27) / 9 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 5, 2025
64980-661-36	64980066136	36 TABLET, FILM COATED in 1 BOTTLE (64980-661-36)Marketed from Jul 23, 2025
64980-661-91	64980066191	1 BLISTER PACK in 1 CARTON (64980-661-91) / 9 TABLET, FILM COATED in 1 BLISTER PACKMarketed from May 5, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): sumatriptan
Generic name (nonproprietary): sumatriptan
Active ingredients: Sumatriptan succinate — 50 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 64980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219036
Marketing start: May 5, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 64980-661_44569522-5e18-4e73-bb20-cac2c0f7a12fSPL ID 44569522-5e18-4e73-bb20-cac2c0f7a12fSPL set ID 352d2ab3-d2c7-48c8-bcd4-d46ed9bdfa85RxCUI 313160, 313161, 315223UNII J8BDZ68989UPC 0364980661362, 0364980660365, 0364980662369
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N464980066127 followed by a unit qualifier and the quantity

Package 64980-0661-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2025.

Indications (excerpt from the label)

Sumatriptan 25 mg, 50 mg and 100 mg tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan tablets, reconsider the diagnosis of migraine before sumatriptan is administered to treat any subsequent attacks. Sumatriptan tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for acute treatment of migraine …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 64980-661

What is NDC 64980-661?: 64980-661 is the product NDC for sumatriptan, Sumatriptan succinate 50 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: sumatriptan.
What is the active ingredient?: Sumatriptan succinate.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 64980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for sumatriptan?: 76 other product NDCs are listed under this name. See all sumatriptan NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other sumatriptan NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Armas Pharmaceuticals Inc.	72485-518	72485-0518-05
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Strides Pharma Science Limited	64380-740	64380-0740-0164380-0740-02
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-151	83270-0151-07
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-152	83270-0152-07
sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	ONESOURCE SPECIALTY PHARMA LIMITED	83270-005	83270-0005-01
sumatriptan	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-660	64980-0660-2764980-0660-3664980-0660-91
sumatriptan	Sumatriptan succinate 100 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-662	64980-0662-2764980-0662-3664980-0662-91
Sumatriptan	Sumatriptan succinate 50 mg/1	Tablet, Film coatedOral	Advanced Rx of Tennessee, LLC	80425-0475	80425-0475-01
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	Caplin Steriles Limited	65145-118	65145-0118-05
Sumatriptan	Sumatriptan succinate 6 mg/.5mL	Injection, SolutionSubcutaneous	A-S Medication Solutions	50090-7957	50090-7957-00

All 77 sumatriptan NDCs

Other NDCs under ANDA 219036

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219036
Product	Strength	Form · route	Labeler	Product NDC
sumatriptan	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-660
sumatriptan	Sumatriptan succinate 100 mg/1	Tablet, Film coatedOral	Rising Pharma Holdings, Inc.	64980-662